Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Fussenegger

Showing results (91-100 of 330) with videos related to

Pageof 33
Sort By:
Integrative Biology : Quantitative Biosciences From Nano to Macro|December 26, 2015
Synthetic biology: applying biological circuits beyond novel therapiesAnton Dobrin, Pratik Saxena, Martin Fussenegger
Advanced Drug Delivery Reviews|May 19, 2016
Toward a world of theranostic medication: Programming biological sentinel systems for therapeutic interventionRyosuke Kojima, Dominique Aubel, Martin Fussenegger
Small (Weinheim an Der Bergstrasse, Germany)|March 20, 2024
Toward Photosynthetic Mammalian Cells through Artificial EndosymbiosisGuipeng Hu, Jinbo Huang, Martin Fussenegger
Biotechnology and Bioengineering|September 9, 2015
Human whole-blood culture system for ex vivo characterization of designer-cell functionLina Schukur, Barbara Geering, Martin Fussenegger
Cellular and Molecular Life Sciences : CMLS|March 19, 2020
Building sophisticated sensors of extracellular cues that enable mammalian cells to work as "doctors" in the bodyRyosuke Kojima, Dominque Aubel, Martin Fussenegger
Current Opinion in Chemical Biology|June 10, 2015
Novel theranostic agents for next-generation personalized medicine: small molecules, nanoparticles, and engineered mammalian cellsRyosuke Kojima, Dominique Aubel, Martin Fussenegger
Biotechnology and Bioengineering|May 28, 2003
Modulation of translation-initiation in CHO-K1 cells by rapamycin-induced heterodimerization of engineered eIF4G fusion proteinsStefan Schlatter, Claudia Senn, Martin Fussenegger
Nature Chemical Biology|November 14, 2017
Nonimmune cells equipped with T-cell-receptor-like signaling for cancer cell ablationRyosuke Kojima, Leo Scheller, Martin Fussenegger
Synthetic Biology (Oxford, England)|April 5, 2021
Engineering precision therapies: lessons and motivations from the clinicMingqi Xie, Mirta Viviani, Martin Fussenegger
Methods in Molecular Biology (Clifton, N.J.)|August 13, 2017
Design of Synthetic Promoters for Gene Circuits in Mammalian CellsPratik Saxena, Daniel Bojar, Martin Fussenegger
Pageof 33

Showing results (91-100 of 330) with videos related to

Sort By:
Pageof 33
Integrative Biology : Quantitative Biosciences From Nano to Macro|December 26, 2015
Synthetic biology: applying biological circuits beyond novel therapiesAnton Dobrin, Pratik Saxena, Martin Fussenegger
Advanced Drug Delivery Reviews|May 19, 2016
Toward a world of theranostic medication: Programming biological sentinel systems for therapeutic interventionRyosuke Kojima, Dominique Aubel, Martin Fussenegger
Small (Weinheim an Der Bergstrasse, Germany)|March 20, 2024
Toward Photosynthetic Mammalian Cells through Artificial EndosymbiosisGuipeng Hu, Jinbo Huang, Martin Fussenegger
Biotechnology and Bioengineering|September 9, 2015
Human whole-blood culture system for ex vivo characterization of designer-cell functionLina Schukur, Barbara Geering, Martin Fussenegger
Cellular and Molecular Life Sciences : CMLS|March 19, 2020
Building sophisticated sensors of extracellular cues that enable mammalian cells to work as "doctors" in the bodyRyosuke Kojima, Dominque Aubel, Martin Fussenegger
Current Opinion in Chemical Biology|June 10, 2015
Novel theranostic agents for next-generation personalized medicine: small molecules, nanoparticles, and engineered mammalian cellsRyosuke Kojima, Dominique Aubel, Martin Fussenegger
Biotechnology and Bioengineering|May 28, 2003
Modulation of translation-initiation in CHO-K1 cells by rapamycin-induced heterodimerization of engineered eIF4G fusion proteinsStefan Schlatter, Claudia Senn, Martin Fussenegger
Nature Chemical Biology|November 14, 2017
Nonimmune cells equipped with T-cell-receptor-like signaling for cancer cell ablationRyosuke Kojima, Leo Scheller, Martin Fussenegger
Synthetic Biology (Oxford, England)|April 5, 2021
Engineering precision therapies: lessons and motivations from the clinicMingqi Xie, Mirta Viviani, Martin Fussenegger
Methods in Molecular Biology (Clifton, N.J.)|August 13, 2017
Design of Synthetic Promoters for Gene Circuits in Mammalian CellsPratik Saxena, Daniel Bojar, Martin Fussenegger
Pageof 33